Trials / Conditions / Stage IV Vulvar Cancer AJCC v8

Stage IV Vulvar Cancer AJCC v8

6 registered clinical trials studyying Stage IV Vulvar Cancer AJCC v8.

Status	Trial	Sponsor	Phase
Withdrawn	Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gyn NCT07226102	City of Hope Medical Center	N/A
Active Not Recruiting	e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gyn NCT05786456	City of Hope Medical Center	N/A
Suspended	Paclitaxel Therapeutic Drug Monitoring in Cancer Patients NCT03987555	Wake Forest University Health Sciences	—
Terminated	DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating P NCT03439085	M.D. Anderson Cancer Center	Phase 2
Completed	Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Me NCT03452332	M.D. Anderson Cancer Center	Phase 1
Terminated	Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervi NCT02140021	M.D. Anderson Cancer Center	N/A